Integrating Bulk and Single-cell RNA-seq to Construct a Macrophage-related Prognostic Model for Prognostic Stratification in Triple-negative Breast Cancer

被引:2
|
作者
Zhao, Hongmeng [1 ,2 ,3 ,4 ]
Zhou, Xuejie [1 ,2 ,3 ,4 ]
Wang, Guixin [1 ,2 ,3 ,4 ]
Yu, Yue [1 ,2 ,3 ,4 ]
Li, Yingxi [5 ]
Chen, Zhaohui [1 ,2 ,3 ,4 ]
Song, Wenbin [6 ]
Zhao, Liwei [6 ]
Wang, Li [2 ,3 ]
Wang, Xin [1 ,2 ,3 ,4 ]
Cao, Xuchen [1 ,2 ,3 ,4 ]
Tian, Yao [1 ,2 ,3 ,4 ,6 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Canc 1, Tianjin 300060, Peoples R China
[2] Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China
[3] Tianjins Clin Res Ctr Canc, Tianjin 300060, Peoples R China
[4] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin 300060, Peoples R China
[5] Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Minist Educ, Tianjin 30007, Peoples R China
[6] Tianjin Med Univ Gen Hosp, Dept Gen Surg, 154 An Shan Rd, Tianjin 300052, Peoples R China
来源
JOURNAL OF CANCER | 2024年 / 15卷 / 18期
基金
中国国家自然科学基金;
关键词
single-cell RNA-seq; triple-negative breast cancer; macrophage; prognostic model; individual treatment; STATISTICS; PLATFORM;
D O I
10.7150/jca.101042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Triple-negative breast cancer (TNBC) is a poor prognostic subtype of breast cancer due to limited treatment. Macrophage plays a critical role in tumor growth and survival. Our study intends to explore the heterogeneity of macrophage in TNBC and establish a macrophage-related prognostic model for TNBC prognostic stratification. Materials and Methods: Seurat package was conducted to analyze the single-cell RNA expression profilers. The cell types were identified by the markers derived from public research and online database. The cell-cell interactions were calculated by the CellChat package. Monocle package was used to visualize the cell trajectory of macrophages. The prognostic model was constructed by six macrophage-related genes after a series of selections. The expression of six genes were validated in normal and TNBC tissues. And several potential agents for high-risk TNBC patients were analyzed by Connectivity Map analysis. Results: Nine cell types were identified, and the macrophages were highly enriched in TNBC samples. five distinct subgroups of macrophage were identified. Notably, SPP1+ tumor-associated macrophages exhibited a poor prognosis. The prognostic model was constructed by HSPA6, LPL, IDO1, ALDH2, TK1, and QPCT with good predictive accuracy at 3-, 5- years overall survival for TNBC patients in both training and external test cohorts. Finally, several drugs were identified for the high-risk TNBC patients decided by model. Conclusion: Our study provides a valuable source for clarifying macrophage heterogeneity in TNBC, and a promising tool for prognostic risk stratification of TNBC.
引用
收藏
页码:6002 / 6015
页数:14
相关论文
共 50 条
  • [1] Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer
    Pei, Shengbin
    Zhang, Pengpeng
    Chen, Huilin
    Zhao, Shuhan
    Dai, Yuhan
    Yang, Lili
    Kang, Yakun
    Zheng, Mingjie
    Xia, Yiqin
    Xie, Hui
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [2] Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer
    Guo, Siyu
    Liu, Xinkui
    Zhang, Jingyuan
    Huang, Zhihong
    Ye, Peizhi
    Shi, Jian
    Stalin, Antony
    Wu, Chao
    Lu, Shan
    Zhang, Fanqin
    Gao, Yifei
    Jin, Zhengseng
    Tao, Xiaoyu
    Huang, Jiaqi
    Zhai, Yiyan
    Shi, Rui
    Guo, Fengying
    Zhou, Wei
    Wu, Jiarui
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 161
  • [3] Integrating Single-Cell RNA-Seq and Bulk RNA-Seq to Construct a Novel γδT Cell-Related Prognostic Signature for Human Papillomavirus-Infected Cervical Cancer
    Wang, Xiaochuan
    Jin, Yichao
    Xu, Liangheng
    Tao, Sizhen
    Wu, Yifei
    Ao, Chunping
    CANCER CONTROL, 2024, 31
  • [4] Integrating single-cell RNA-seq and bulk RNA-seq to construct a neutrophil prognostic model for predicting prognosis and immune response in oral squamous cell carcinoma
    Jinhang Wang
    Zifeng Cui
    Qiwen Song
    Kaicheng Yang
    Yanping Chen
    Shixiong Peng
    Human Genomics, 18 (1)
  • [5] Integrating single-cell RNA-seq and bulk RNA-seq to explore prognostic value and immune landscapes of methionine metabolism-related signature in breast cancer
    Gao, Yanxian
    Feng, Ziyu
    Zhao, Hailong
    Liu, Xinghai
    Zhu, Muyu
    Yu, Xiafei
    Liu, Xiaoan
    Wu, Xian
    Tao, Jing
    FRONTIERS IN GENETICS, 2025, 15
  • [6] Integration of Bulk and Single-Cell RNA-Seq Data to Construct a Prognostic Model of Membrane Tension-Related Genes for Colon Cancer
    Li, Jiacheng
    Fu, Yugang
    Zhang, Kehui
    Li, Yong
    VACCINES, 2022, 10 (09)
  • [7] Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer
    Ding, Peikai
    Pei, Shengbin
    Qu, Zheng
    Yang, Yazhe
    Liu, Qiang
    Kong, Xiangyi
    Wang, Zhongzhao
    Wang, Jing
    Fang, Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer
    Shen, Liang
    Li, Aihua
    Cui, Jing
    Liu, Haixia
    Zhang, Shiqian
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [9] Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC
    Zhang, Xing
    Yang, Longkun
    Deng, Ying
    Huang, Zhicong
    Huang, Hao
    Wu, Yuying
    He, Baochang
    Hu, Fulan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 9805 - 9821
  • [10] Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC
    Xing Zhang
    Longkun Yang
    Ying Deng
    Zhicong Huang
    Hao Huang
    Yuying Wu
    Baochang He
    Fulan Hu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 9805 - 9821